Addex Therapeutics Ltd (ADXN)
8.11
+0.73
(+9.89%)
USD |
NASDAQ |
Nov 21, 16:00
7.99
-0.12
(-1.48%)
Pre-Market: 08:01
Addex Therapeutics Shareholders Equity (Quarterly): 14.07M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 14.07M |
| March 31, 2024 | -1.522M |
| December 31, 2023 | 1.364M |
| September 30, 2023 | 4.311M |
| June 30, 2023 | 6.812M |
| March 31, 2023 | 4.457M |
| December 31, 2022 | 5.299M |
| September 30, 2022 | 8.154M |
| June 30, 2022 | 7.191M |
| March 31, 2022 | 14.03M |
| December 31, 2021 | 18.52M |
| September 30, 2021 | 14.28M |
| June 30, 2021 | 17.83M |
| March 31, 2021 | 21.97M |
| December 31, 2020 | 16.72M |
| September 30, 2020 | 17.12M |
| June 30, 2020 | 19.77M |
| March 31, 2020 | 22.69M |
| December 31, 2019 | 26.34M |
| June 30, 2019 | 33.04M |
| December 31, 2018 | 39.86M |
| June 30, 2018 | 42.37M |
| June 30, 2018 | 42.37M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.378M |
| June 30, 2017 | 2.490M |
| June 30, 2017 | 2.490M |
| December 31, 2016 | 0.2148M |
| June 30, 2016 | 1.205M |
| June 30, 2016 | 1.205M |
| December 31, 2015 | 1.684M |
| June 30, 2015 | 2.954M |
| June 30, 2015 | 2.954M |
| December 31, 2014 | 2.372M |
| June 30, 2014 | 2.300M |
| June 30, 2014 | 2.300M |
| December 31, 2013 | 3.410M |
| June 30, 2013 | 3.050M |
| June 30, 2013 | 3.050M |
| December 31, 2012 | 15.68M |
| June 30, 2012 | 20.17M |
| June 30, 2012 | 20.17M |
| December 31, 2011 | 33.99M |
| June 30, 2011 | 59.78M |
| December 31, 2010 | 68.91M |
| June 30, 2010 | 56.06M |
| December 31, 2009 | 74.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.522M
Minimum
Mar 2024
26.34M
Maximum
Dec 2019
12.60M
Average
14.07M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 154.72M |
| CRISPR Therapeutics AG | 1.940B |
| NLS Pharmaceutics Ltd | -9.268M |
| Molecular Partners AG | 164.96M |
| MoonLake Immunotherapeutics | 488.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.24M |
| Total Liabilities (Quarterly) | 1.164M |
| Current Ratio | 4.974 |